These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 12844288)

  • 1. The uterine cervix--a new member of the family of immunologically exceptional sites?
    Höglund P; Kärre K; Klein G
    Cancer Immun; 2003 Jul; 3():6. PubMed ID: 12844288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix.
    Delvenne P; Herman L; Kholod N; Caberg JH; Herfs M; Boniver J; Jacobs N; Hubert P
    Mol Cell Endocrinol; 2007 Jan; 264(1-2):1-5. PubMed ID: 17145130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Local immune responses in uterine cervical carcinogenesis].
    Takehara K
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Nov; 48(11):1063-70. PubMed ID: 8940695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological microenvironments in the human vagina and cervix: mediators of cellular immunity are concentrated in the cervical transformation zone.
    Pudney J; Quayle AJ; Anderson DJ
    Biol Reprod; 2005 Dec; 73(6):1253-63. PubMed ID: 16093359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host immune responses to cervical cancer.
    Patel S; Chiplunkar S
    Curr Opin Obstet Gynecol; 2009 Feb; 21(1):54-9. PubMed ID: 19125004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Studies on pathogenesis of cervical carcinoma based on the analysis of growth and differentiation mechanism of cervical epithelium].
    Konishi I
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Aug; 42(8):812-22. PubMed ID: 2172418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune cellular response to HPV: current concepts.
    Gonçalves MA; Donadi EA
    Braz J Infect Dis; 2004 Feb; 8(1):1-9. PubMed ID: 15137933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
    Purtilo DT; Manolov G; Manolova Y; Harada S; Lipscomb H
    IARC Sci Publ; 1984; (63):749-70. PubMed ID: 6100288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and epidemiological correlations between the infection with HPV 16 and HPV 18 and female cervical lesions.
    Stoian M; Repanovici R; Corniţescu F
    Rom J Virol; 1995; 46(3-4):161-70. PubMed ID: 9179967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical status and expression of HPV genes in cervical cancers.
    Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
    Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic vaccine to control stromal tumor-induced immunosuppression in human uterine cervixc cancer.
    Le Buanec H; Cohen L; Paturance S; Burny A; Gallo RC; Zagury D
    Cell Mol Biol (Noisy-le-grand); 2003 Jun; 49(4):667-71. PubMed ID: 12899461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vision of cell death: Fas ligand and immune privilege 10 years later.
    Ferguson TA; Griffith TS
    Immunol Rev; 2006 Oct; 213():228-38. PubMed ID: 16972907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Termination of systemic immunity in the presence of intraocular tumors: influence of ocular immune privilege on tumor vaccines.
    Chen PW; Ksander BR
    Curr Eye Res; 2006 Jan; 31(1):43-55. PubMed ID: 16421019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunity of the female genital tract mucosa and mechanisms of papillomavirus evasion].
    Riethmuller D; Seilles E
    J Gynecol Obstet Biol Reprod (Paris); 2000 Dec; 29(8):729-740. PubMed ID: 11139708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune evasion in human papillomavirus-associated cervical cancer.
    Tindle RW
    Nat Rev Cancer; 2002 Jan; 2(1):59-65. PubMed ID: 11902586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular autoimmunity: the price of privilege?
    Caspi RR
    Immunol Rev; 2006 Oct; 213():23-35. PubMed ID: 16972894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytologic and histologic manifestations of human papillomavirus infection of the uterine cervix.
    Koss LG
    Cancer Detect Prev; 1990; 14(4):461-4. PubMed ID: 2171769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue effects of and host response to human papillomavirus infection.
    Jenson AB; Kurman RJ; Lancaster WD
    Dermatol Clin; 1991 Apr; 9(2):203-9. PubMed ID: 1647900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytokine-based transformation of immune surveillance into tumor-promoting inflammation.
    Mumm JB; Oft M
    Oncogene; 2008 Oct; 27(45):5913-9. PubMed ID: 18836472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
    Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
    J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.